Loss of MICOS complex integrity and mitochondrial damage, but not TDP-43 mitochondrial localisation, are likely associated with severity of CHCHD10-related diseases

[1]  S. Westerheide,et al.  Loss of function CHCHD10 mutations in cytoplasmic TDP-43 accumulation and synaptic integrity , 2017, Nature Communications.

[2]  Wenzhang Wang,et al.  Motor-Coordinative and Cognitive Dysfunction Caused by Mutant TDP-43 Could Be Reversed by Inhibiting Its Mitochondrial Localization. , 2017, Molecular therapy : the journal of the American Society of Gene Therapy.

[3]  B. Udd,et al.  CHCHD10 mutations and motor neuron disease: the distribution in Finnish patients , 2016, Journal of Neurology, Neurosurgery & Psychiatry.

[4]  Kara L. Cerveny,et al.  Coincident Phosphatidic Acid Interaction Restrains Drp1 in Mitochondrial Division. , 2016, Molecular cell.

[5]  Ivan Dikic,et al.  Common Molecular Pathways in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. , 2016, Trends in molecular medicine.

[6]  P. Bénit,et al.  QIL1 mutation causes MICOS disassembly and early onset fatal mitochondrial encephalopathy with liver disease , 2016, eLife.

[7]  Hu Li,et al.  The Inhibition of TDP-43 Mitochondrial Localization Blocks Its Neuronal Toxicity , 2016, Nature Medicine.

[8]  J. Joutsa,et al.  Evolving neuromuscular phenotype in a patient with a heterozygous CHCHD10 p.G66V mutation , 2016, Journal of Neurology.

[9]  S. Kiuru-Enari,et al.  Intrafamilial clinical variability in individuals carrying the CHCHD10 mutation Gly66Val , 2016, Acta Neurologica Scandinavica.

[10]  E. Génin,et al.  CHCHD10 mutations promote loss of mitochondrial cristae junctions with impaired mitochondrial genome maintenance and inhibition of apoptosis , 2015, EMBO molecular medicine.

[11]  L. Petrucelli,et al.  TAR DNA‐binding protein 43 and pathological subtype of Alzheimer's disease impact clinical features , 2015, Annals of neurology.

[12]  E. Buratti,et al.  TDP-43 affects splicing profiles and isoform production of genes involved in the apoptotic and mitotic cellular pathways , 2015, Nucleic acids research.

[13]  Justin Yamada,et al.  MICOS coordinates with respiratory complexes and lipids to establish mitochondrial inner membrane architecture , 2015, eLife.

[14]  A. Paetau,et al.  CHCHD10 variant p.(Gly66Val) causes axonal Charcot-Marie-Tooth disease , 2015, Neurology: Genetics.

[15]  S. Rossi,et al.  Mitochondrial dynamism and the pathogenesis of Amyotrophic Lateral Sclerosis , 2015, Front. Cell. Neurosci..

[16]  B. Udd,et al.  Late onset spinal motor neuronopathy is caused by mutation in CHCHD10 , 2015, Annals of neurology.

[17]  A. Brice,et al.  Screening of CHCHD10 in a French cohort confirms the involvement of this gene in frontotemporal dementia with amyotrophic lateral sclerosis patients , 2014, Neurobiology of Aging.

[18]  E. Génin,et al.  A mitochondrial origin for frontotemporal dementia and amyotrophic lateral sclerosis through CHCHD10 involvement. , 2014, Brain : a journal of neurology.

[19]  L. Petrucelli,et al.  The ALS disease-associated mutant TDP-43 impairs mitochondrial dynamics and function in motor neurons. , 2013, Human molecular genetics.

[20]  C. van Broeckhoven,et al.  Pathological mechanisms underlying TDP-43 driven neurodegeneration in FTLD–ALS spectrum disorders , 2013, Human molecular genetics.

[21]  J. Pouget,et al.  The MFN2 gene is responsible for mitochondrial DNA instability and optic atrophy 'plus' phenotype. , 2012, Brain : a journal of neurology.

[22]  Bruce L. Miller,et al.  Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS , 2011, Neuron.

[23]  David Heckerman,et al.  A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD , 2011, Neuron.

[24]  H. Sesaki,et al.  Mitochondrial division: molecular machinery and physiological functions. , 2011, Current opinion in cell biology.

[25]  L. Petrucelli,et al.  Wild-Type Human TDP-43 Expression Causes TDP-43 Phosphorylation, Mitochondrial Aggregation, Motor Deficits, and Early Mortality in Transgenic Mice , 2010, The Journal of Neuroscience.

[26]  A. Echaniz-Laguna,et al.  TDP43-Positive Intraneuronal Inclusions in a Patient with Motor Neuron Disease and Parkinson’s Disease , 2010, Neurodegenerative Diseases.

[27]  A. B. Knott,et al.  Impairing the Mitochondrial Fission and Fusion Balance: A New Mechanism of Neurodegeneration , 2008, Annals of the New York Academy of Sciences.

[28]  B. McConkey,et al.  TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis , 2008, Nature Genetics.

[29]  Xun Hu,et al.  TDP-43 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis , 2008, Science.

[30]  Lichuan Yang,et al.  Assay of mitochondrial ATP synthesis in animal cells and tissues. , 2007, Methods in cell biology.

[31]  H. Akiyama,et al.  TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. , 2006, Biochemical and biophysical research communications.

[32]  H. Ressom,et al.  Activation of p53-Dependent Growth Suppression in Human Cells by Mutations in PTEN or PIK3CA , 2006, Molecular and Cellular Biology.

[33]  Bruce L. Miller,et al.  Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis , 2006, Science.

[34]  M. Pericak-Vance,et al.  Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A , 2004, Nature Genetics.

[35]  N. Henderson,et al.  Blue Native electrophoresis to study mitochondrial and other protein complexes. , 2002, Methods.

[36]  T. Dörk,et al.  Nuclear factor TDP‐43 and SR proteins promote in vitro and in vivo CFTR exon 9 skipping , 2001, The EMBO journal.

[37]  S. Bhattacharya,et al.  OPA1, encoding a dynamin-related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28 , 2000, Nature Genetics.

[38]  B. Godley,et al.  Hydrogen peroxide causes significant mitochondrial DNA damage in human RPE cells. , 1999, Experimental eye research.

[39]  A. M. van der Bliek,et al.  A Human Dynamin-related Protein Controls the Distribution of Mitochondria , 1998, The Journal of cell biology.

[40]  A. Lezza,et al.  Mitochondrial DNA Deletions , 1998 .

[41]  T. Bourgeron,et al.  Biochemical and molecular investigations in respiratory chain deficiencies. , 1994, Clinica chimica acta; international journal of clinical chemistry.

[42]  D. Wallace,et al.  Nonviability of cells with oxidative defects in galactose medium: a screening test for affected patient fibroblasts. , 1992, Biochemical medicine and metabolic biology.

[43]  S. Dimauro,et al.  Mitochondrial DNA deletions in progressive external ophthalmoplegia and Kearns-Sayre syndrome. , 1989, The New England journal of medicine.